Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MATRIX TABLET CAPABLE OF CONTINUOUSLY RELEASING SODIUM TIANEPTINE AFTER ORAL ADMINISTRATION
Document Type and Number:
Japanese Patent JPH1036268
Kind Code:
A
Abstract:

To obtain the subject preparation capable of completely controlling the release of active ingredients and continuously releasing sodium tianeptine by combining a polymer originating from cellulose and a calcium salt.

This preparation is matrix tablets for continuously releasing sodium tianeptine prepared by using a polymer originating from cellulose (preferably methylhydroxy-propylcellulose) and a calcium salt (preferably calcium hydrogenphosphate dihydrate). The ratio between the cellulose derivative and the calcium salt is preferably in the range 30-50wt.% to 10-60wt.%, respectively, based on the whole weight of the tablets. By this matrix tablet, tianeptine is continuously released and as the result, the blood concentration of 50-300mg/ml is obtainable even at 24 hours after the administration in human.


Inventors:
HUET DE BAROCHEZ BRUNO
WUTHRICH PATRICK
Application Number:
JP9558997A
Publication Date:
February 10, 1998
Filing Date:
April 14, 1997
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ADIR
International Classes:
A61K9/20; A61K9/22; A61K31/55; A61K31/554; A61K47/02; C07D281/02; A61K47/38; A61P25/24; A61P25/26; (IPC1-7): A61K31/55; A61K9/20; A61K47/02; A61K47/38
Attorney, Agent or Firm:
Hajime Tsukuni (2 outside)